We read with great interest the case report by Ratajczak and colleagues[@bib1] of late-onset asystolic episodes in a patient with a vagal nerve stimulator that were successfully treated by pacemaker implantation.

In this particular case, excessive iatrogenic parasympathetic stimulation of the cardiac conduction system with the vagal stimulator was presumed to be the mechanism of bradyarrhythmias. A variety of different clinical conditions could result in similar cardioinhibition as a result of *endogenously* enhanced parasympathetic tone, such as cardioinhibitory syncope, carotid sinus syndrome, and ictal asystole. Pacemaker implantation is a viable treatment option in such cases. However, complications rates due to a pacemaker during long-term follow-up are not low, ranging from 7.5% to almost 10% of patients. In addition, chronic pacing of the right ventricle could be detrimental to cardiac function.[@bib2]

Cardioneuroablation is an emerging option for treatment of cardioinhibitory neurocardiogenic syncope, with promising long-term results.[@bib3] This minimally invasive technique is based on radiofrequency ablation of the main epicardial parasympathetic ganglia in the heart, with the aim of modifying the abnormally enhanced cardiac vagal tone. Using this ablation procedure in our center, we successfully treated a patient with ictal asystole and were able to convert the patient\'s dramatic seizures with severe cerebral hypoperfusion to short focal seizures with minimal motor sign. Therefore, we strongly believe that cardioneuroablation also could be considered in the presented case.
